sb 203580 has been researched along with 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one in 3 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one) | Trials (6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one) | Recent Studies (post-2010) (6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 195 | 0 | 30 |
| Protein | Taxonomy | sb 203580 (IC50) | 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one (IC50) |
|---|---|---|---|
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, GN; Yellaturu, CR | 1 |
| Han, C; Shelhamer, JH; Wu, T | 1 |
| Finkel, MS; Kan, H; Xie, Z | 1 |
3 other study(ies) available for sb 203580 and 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one
| Article | Year |
|---|---|
A requirement for calcium-independent phospholipase A2 in thrombin-induced arachidonic acid release and growth in vascular smooth muscle cells.
Topics: Animals; Arachidonic Acid; Blotting, Western; Coloring Agents; DNA; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Group VI Phospholipases A2; Imidazoles; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Naphthalenes; Oleic Acid; Oligonucleotides, Antisense; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phospholipases A2; Pyridines; Pyrones; Rats; Rats, Sprague-Dawley; Signal Transduction; Tetrazolium Salts; Thiazoles; Thrombin; Time Factors | 2003 |
Involvement of p38 and p42/44 MAP kinases and protein kinase C in the interferon-gamma and interleukin-1alpha-induced phosphorylation of 85-kDa cytosolic phospholipase A(2) in primary human bronchial epithelial cells.
Topics: Arachidonic Acid; Arachidonic Acids; Bronchi; Cells, Cultured; Cytosol; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Flavonoids; Humans; Imidazoles; Interferon-gamma; Interleukin-1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Naphthalenes; Organophosphonates; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phosphorylation; Protein Kinase C; Pyridines; Pyrones | 2004 |
iPLA2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytes.
Topics: Activating Transcription Factor 2; Animals; Enzyme Inhibitors; Group VI Phospholipases A2; Heart Ventricles; HIV Envelope Protein gp120; Imidazoles; Intracellular Signaling Peptides and Proteins; Male; Myocytes, Cardiac; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phosphorylation; Protein Serine-Threonine Kinases; Pyridines; Pyrones; Rats; Rats, Sprague-Dawley; Signal Transduction; Troponin I | 2006 |